Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-13

Clinical Trial Update: Fostemsavir Compassionate Use Named Patient Program for the Treatment of Human Immunodeficiency Virus 1 (HIV-1)

View source ↗

Summary

This clinical-trial update describes ViiV Healthcare's compassionate-use named-patient program for fostemsavir to treat HIV-1 infection.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fostemsavir (fostemsavir)

Snippet

Sponsor: ViiV Healthcare | Conditions: HIV Infections | Status: AVAILABLE